サマリー

ベータラクタムおよびベータラクタマーゼ阻害剤の世界市場 2022-2026 年
Technavioは、ベータラクタムおよびベータラクタマーゼ阻害剤市場を監視しており、2022-2026年の間に90億4000万ドルの成長が見込まれ、予測期間中にCAGR 5.44％で加速しています。当レポートでは、β-ラクタムおよびβ-ラクタマーゼ阻害剤市場の全体分析、市場規模および予測、トレンド、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境について最新の分析を提供しています。市場は、特別な規制指定、OTC医薬品の容易な入手、低・中所得国での消費拡大などによって牽引されています。
β-ラクタムおよびβ-ラクタマーゼ阻害剤市場の分析には、投与セグメントと地理的な状況も含まれます。
Technavioのβ-ラクタムおよびβ-ラクタマーゼ阻害剤市場は、以下のようにセグメント化されています。
地理的状況別
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、今後数年間におけるベータラクタムおよびベータラクタマーゼ阻害剤市場の成長を促進する主な理由の1つとして、感染症の蔓延が挙げられています。また、戦略的提携やM&A、老年人口の増加も、市場の大きな需要につながると考えられます。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。ベータラクタムおよびベータラクタマーゼ阻害剤市場に関する当レポートは、以下の分野を対象としています。
- βラクタムおよびβラクタマーゼ阻害剤市場のサイジング
- β-ラクタムおよびβ-ラクタマーゼ阻害剤の市場予測
- ベータラクタムおよびベータラクタマーゼ阻害剤市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って、本レポートでは、Abbott Laboratories、AbbVie Inc.を含むいくつかの主要ベータラクタムとベータラクタマーゼ阻害剤市場のベンダーについて詳細に分析しています。Aristo Pharmaceuticals Pvt Ltd., Aurobindo Pharma Ltd., Cadila Pharmaceuticals Ltd., Cipla Ltd., Dr. Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Johnson and Johnson, Livealth Biopharma Pvt. Ltd., Merck and Co.Inc.、Novartis AG、Pfizer Inc.、Pragati Biocare Pvt. Ltd.、Sanofi、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd.、Viatris Inc、およびZydus Lifesciences Ltd.である。また、β-ラクタムおよびβ-ラクタマーゼ阻害剤市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/beta-lactam-and-beta-lactamase-inhibitors-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Route of Administration
o 5.1 Market segments
o Exhibit 24: Chart on Route of Administration - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Route of Administration - Market share 2021-2026 (%)
o 5.2 Comparison by Route of Administration
o Exhibit 26: Chart on Comparison by Route of Administration
o Exhibit 27: Data Table on Comparison by Route of Administration
o 5.3 Oral - Market size and forecast 2021-2026
o Exhibit 28: Chart on Oral - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Oral - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Oral - Year-over-year growth 2021-2026 (%)
o 5.4 Intravenous - Market size and forecast 2021-2026
o Exhibit 32: Chart on Intravenous - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Intravenous - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Intravenous - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Intravenous - Year-over-year growth 2021-2026 (%)
o 5.5 Others - Market size and forecast 2021-2026
o Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Route of Administration
o Exhibit 40: Market opportunity by Route of Administration ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Denmark - Market size and forecast 2021-2026
o Exhibit 66: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Denmark - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
o 7.9 China - Market size and forecast 2021-2026
o Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 India - Market size and forecast 2021-2026
o Exhibit 78: Chart on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on India - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on India - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on India - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 Abbott Laboratories
o Exhibit 89: Abbott Laboratories - Overview
o Exhibit 90: Abbott Laboratories - Business segments
o Exhibit 91: Abbott Laboratories - Key news
o Exhibit 92: Abbott Laboratories - Key offerings
o Exhibit 93: Abbott Laboratories - Segment focus
o 10.4 AbbVie Inc.
o Exhibit 94: AbbVie Inc. - Overview
o Exhibit 95: AbbVie Inc. - Product / Service
o Exhibit 96: AbbVie Inc. - Key offerings
o 10.5 Aristo Pharmaceuticals Pvt Ltd.
o Exhibit 97: Aristo Pharmaceuticals Pvt Ltd. - Overview
o Exhibit 98: Aristo Pharmaceuticals Pvt Ltd. - Product / Service
o Exhibit 99: Aristo Pharmaceuticals Pvt Ltd. - Key offerings
o 10.6 Cipla Ltd.
o Exhibit 100: Cipla Ltd. - Overview
o Exhibit 101: Cipla Ltd. - Business segments
o Exhibit 102: Cipla Ltd. - Key news
o Exhibit 103: Cipla Ltd. - Key offerings
o Exhibit 104: Cipla Ltd. - Segment focus
o 10.7 Dr. Reddys Laboratories Ltd.
o Exhibit 105: Dr. Reddys Laboratories Ltd. - Overview
o Exhibit 106: Dr. Reddys Laboratories Ltd. - Business segments
o Exhibit 107: Dr. Reddys Laboratories Ltd. - Key offerings
o Exhibit 108: Dr. Reddys Laboratories Ltd. - Segment focus
o 10.8 F. Hoffmann La Roche Ltd.
o Exhibit 109: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 110: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 111: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 112: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 113: F. Hoffmann La Roche Ltd. - Segment focus
o 10.9 GlaxoSmithKline Plc
o Exhibit 114: GlaxoSmithKline Plc - Overview
o Exhibit 115: GlaxoSmithKline Plc - Business segments
o Exhibit 116: GlaxoSmithKline Plc - Key news
o Exhibit 117: GlaxoSmithKline Plc - Key offerings
o Exhibit 118: GlaxoSmithKline Plc - Segment focus
o 10.10 Johnson and Johnson
o Exhibit 119: Johnson and Johnson - Overview
o Exhibit 120: Johnson and Johnson - Business segments
o Exhibit 121: Johnson and Johnson - Key news
o Exhibit 122: Johnson and Johnson - Key offerings
o Exhibit 123: Johnson and Johnson - Segment focus
o 10.11 Merck and Co. Inc.
o Exhibit 124: Merck and Co. Inc. - Overview
o Exhibit 125: Merck and Co. Inc. - Business segments
o Exhibit 126: Merck and Co. Inc. - Key news
o Exhibit 127: Merck and Co. Inc. - Key offerings
o Exhibit 128: Merck and Co. Inc. - Segment focus
o 10.12 Pfizer Inc.
o Exhibit 129: Pfizer Inc. - Overview
o Exhibit 130: Pfizer Inc. - Product / Service
o Exhibit 131: Pfizer Inc. - Key news
o Exhibit 132: Pfizer Inc. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 133: Inclusions checklist
o Exhibit 134: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 135: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 136: Research methodology
o Exhibit 137: Validation techniques employed for market sizing
o Exhibit 138: Information sources
o 11.5 List of abbreviations
o Exhibit 139: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Route of Administration - Market share 2021-2026 (%)
Exhibits25: Data Table on Route of Administration - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Route of Administration
Exhibits27: Data Table on Comparison by Route of Administration
Exhibits28: Chart on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Oral - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Oral - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Intravenous - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Intravenous - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Intravenous - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Intravenous - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Route of Administration ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Denmark - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on India - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: Abbott Laboratories - Overview
Exhibits90: Abbott Laboratories - Business segments
Exhibits91: Abbott Laboratories - Key news
Exhibits92: Abbott Laboratories - Key offerings
Exhibits93: Abbott Laboratories - Segment focus
Exhibits94: AbbVie Inc. - Overview
Exhibits95: AbbVie Inc. - Product / Service
Exhibits96: AbbVie Inc. - Key offerings
Exhibits97: Aristo Pharmaceuticals Pvt Ltd. - Overview
Exhibits98: Aristo Pharmaceuticals Pvt Ltd. - Product / Service
Exhibits99: Aristo Pharmaceuticals Pvt Ltd. - Key offerings
Exhibits100: Cipla Ltd. - Overview
Exhibits101: Cipla Ltd. - Business segments
Exhibits102: Cipla Ltd. - Key news
Exhibits103: Cipla Ltd. - Key offerings
Exhibits104: Cipla Ltd. - Segment focus
Exhibits105: Dr. Reddys Laboratories Ltd. - Overview
Exhibits106: Dr. Reddys Laboratories Ltd. - Business segments
Exhibits107: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibits108: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibits109: F. Hoffmann La Roche Ltd. - Overview
Exhibits110: F. Hoffmann La Roche Ltd. - Business segments
Exhibits111: F. Hoffmann La Roche Ltd. - Key news
Exhibits112: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits113: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits114: GlaxoSmithKline Plc - Overview
Exhibits115: GlaxoSmithKline Plc - Business segments
Exhibits116: GlaxoSmithKline Plc - Key news
Exhibits117: GlaxoSmithKline Plc - Key offerings
Exhibits118: GlaxoSmithKline Plc - Segment focus
Exhibits119: Johnson and Johnson - Overview
Exhibits120: Johnson and Johnson - Business segments
Exhibits121: Johnson and Johnson - Key news
Exhibits122: Johnson and Johnson - Key offerings
Exhibits123: Johnson and Johnson - Segment focus
Exhibits124: Merck and Co. Inc. - Overview
Exhibits125: Merck and Co. Inc. - Business segments
Exhibits126: Merck and Co. Inc. - Key news
Exhibits127: Merck and Co. Inc. - Key offerings
Exhibits128: Merck and Co. Inc. - Segment focus
Exhibits129: Pfizer Inc. - Overview
Exhibits130: Pfizer Inc. - Product / Service
Exhibits131: Pfizer Inc. - Key news
Exhibits132: Pfizer Inc. - Key offerings
Exhibits133: Inclusions checklist
Exhibits134: Exclusions checklist
Exhibits135: Currency conversion rates for US$
Exhibits136: Research methodology
Exhibits137: Validation techniques employed for market sizing
Exhibits138: Information sources
Exhibits139: List of abbreviations